As gene therapies move toward commercialization, a robust, scalable and affordable manufacturing process is critical. In this exclusive article, Pall Biotech partners with Cell Culture Dish to explore how optimizing your process with an automated, end-to-end solution reduces costs, speeds you to market, and gets the final product within reach of patients.
|